Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $5,000 | 1 | 67.1% |
| Food and Beverage | $2,269 | 125 | 30.4% |
| Education | $187.50 | 1 | 2.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Katena Products, Inc. | $5,000 | 1 | $0 (2018) |
| Aerie Pharmaceuticals, Inc. | $544.92 | 14 | $0 (2021) |
| Allergan, Inc. | $271.64 | 12 | $0 (2022) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $260.36 | 16 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $219.89 | 13 | $0 (2022) |
| ABBVIE INC. | $190.17 | 11 | $0 (2024) |
| Bausch & Lomb Americas Inc. | $157.95 | 8 | $0 (2024) |
| Shire North American Group Inc | $131.66 | 11 | $0 (2018) |
| Kala Pharmaceuticals, Inc. | $98.79 | 7 | $0 (2021) |
| Mallinckrodt Hospital Products Inc. | $83.25 | 5 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $297.79 | 17 | BIOTISSUE HOLDINGS INC. ($80.44) |
| 2023 | $252.18 | 11 | AbbVie Inc. ($90.22) |
| 2022 | $242.77 | 15 | Mallinckrodt Hospital Products Inc. ($83.25) |
| 2021 | $287.52 | 18 | Bausch & Lomb, a division of Bausch Health US, LLC ($71.48) |
| 2020 | $81.55 | 5 | Bausch & Lomb, a division of Bausch Health US, LLC ($36.82) |
| 2019 | $765.28 | 27 | Aerie Pharmaceuticals, Inc. ($367.90) |
| 2018 | $5,348 | 20 | Katena Products, Inc. ($5,000) |
| 2017 | $182.00 | 14 | Shire North American Group Inc ($81.45) |
All Payment Transactions
127 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 11/27/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: Ophthalmology | ||||||
| 11/25/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | Cash or cash equivalent | $22.41 | General |
| 10/31/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | In-kind items and services | $22.41 | General |
| 10/23/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/02/2024 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $23.11 | General |
| Category: SOLUTION/ DROPS | ||||||
| 09/18/2024 | NEW WORLD MEDICAL,INC. | Kahook Dual Blade (Device), Clearpath, Ahmed Glaucoma Valve | Food and Beverage | In-kind items and services | $8.55 | General |
| Category: Ophthalmology | ||||||
| 07/22/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | Cash or cash equivalent | $18.25 | General |
| 07/18/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Food and Beverage | In-kind items and services | $20.62 | General |
| Category: Ophthalmology | ||||||
| 05/30/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: EYE CARE | ||||||
| 05/23/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: Inflammation/Rare Disease | ||||||
| 05/09/2024 | Alcon Vision LLC | Rocklatan (Drug) | Food and Beverage | In-kind items and services | $24.53 | General |
| Category: Ophthalmology | ||||||
| 04/29/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug), MIEBO | Food and Beverage | In-kind items and services | $22.75 | General |
| Category: Ophthalmology | ||||||
| 04/15/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | In-kind items and services | $17.37 | General |
| 03/25/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: EYE CARE | ||||||
| 02/22/2024 | NEW WORLD MEDICAL,INC. | Kahook Dual Blade (Device), Clearpath, Ahmed Glaucoma Valve | Food and Beverage | In-kind items and services | $9.19 | General |
| Category: Ophthalmology | ||||||
| 01/31/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: EYE CARE | ||||||
| 12/11/2023 | AbbVie Inc. | LUMIGAN (Drug), ALPHAGAN P | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: EYE CARE | ||||||
| 11/13/2023 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Food and Beverage | In-kind items and services | $23.75 | General |
| Category: Ophthalmology | ||||||
| 10/04/2023 | AbbVie Inc. | LUMIGAN (Drug), ALPHAGAN P | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: EYE CARE | ||||||
| 09/06/2023 | AbbVie Inc. | VUITY (Drug), LUMIGAN | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: EYE CARE | ||||||
| 08/29/2023 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $24.43 | General |
| Category: Ophthalmology | ||||||
| 08/23/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $27.59 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 07/19/2023 | Glaukos Corporation | — | Food and Beverage | Cash or cash equivalent | $47.54 | General |
| 05/15/2023 | Bausch & Lomb Americas Inc. | VYZULTA (Drug), LOTEMAX SM | Food and Beverage | In-kind items and services | $20.45 | General |
| Category: Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 2,197 | 2,651 | $625,883 | $218,644 |
| 2022 | 19 | 2,357 | 2,721 | $541,836 | $201,461 |
| 2021 | 19 | 2,502 | 2,859 | $578,105 | $225,077 |
| 2020 | 17 | 2,279 | 2,571 | $553,950 | $209,650 |
All Medicare Procedures & Services
71 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 338 | 555 | $133,755 | $47,127 | 35.2% |
| 66250 | Revision or repair of operative wound of eye | Office | 2023 | 43 | 48 | $69,744 | $26,305 | 37.7% |
| 66180 | Creation of shunt to improve eye fluid flow using tissue graft | Facility | 2023 | 27 | 28 | $61,320 | $23,818 | 38.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 261 | 425 | $72,250 | $23,799 | 32.9% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 504 | 513 | $58,995 | $21,595 | 36.6% |
| 66170 | Creation of eye fluid drainage tract for treatment of glaucoma | Facility | 2023 | 19 | 21 | $44,079 | $16,709 | 37.9% |
| 66172 | Creation of eye fluid drainage tract for treatment of glaucoma with previous scarring | Facility | 2023 | 13 | 14 | $32,046 | $12,466 | 38.9% |
| 92133 | Imaging of optic nerve | Office | 2023 | 492 | 495 | $49,500 | $11,666 | 23.6% |
| 66761 | Creation of eye fluid drainage tracts in iris using a laser, per session | Office | 2023 | 27 | 47 | $26,363 | $9,747 | 37.0% |
| 65855 | Laser repair to improve eye fluid flow | Office | 2023 | 38 | 53 | $31,800 | $9,110 | 28.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 48 | 48 | $15,744 | $5,800 | 36.8% |
| 92020 | Exam of the internal drainage system of eye | Office | 2023 | 235 | 247 | $12,844 | $4,791 | 37.3% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 29 | 31 | $7,285 | $2,386 | 32.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 25 | 25 | $5,500 | $1,720 | 31.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 26 | 29 | $3,074 | $1,022 | 33.3% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2023 | 72 | 72 | $1,584 | $583.20 | 36.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 450 | 641 | $84,317 | $34,916 | 41.4% |
| 66250 | Revision or repair of operative wound of eye | Office | 2022 | 38 | 45 | $42,140 | $24,664 | 58.5% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 506 | 511 | $55,575 | $20,829 | 37.5% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 246 | 345 | $37,446 | $19,372 | 51.7% |
| 66170 | Creation of eye fluid drainage tract for treatment of glaucoma | Facility | 2022 | 19 | 23 | $39,893 | $19,138 | 48.0% |
| 66180 | Creation of shunt to improve eye fluid flow using tissue graft | Facility | 2022 | 19 | 19 | $62,750 | $16,522 | 26.3% |
| 66761 | Creation of eye fluid drainage tracts in iris using a laser, per session | Office | 2022 | 32 | 61 | $55,775 | $13,763 | 24.7% |
| 66172 | Creation of eye fluid drainage tract for treatment of glaucoma with previous scarring | Facility | 2022 | 13 | 14 | $25,567 | $12,534 | 49.0% |
| 92133 | Imaging of optic nerve | Office | 2022 | 484 | 490 | $42,902 | $11,566 | 27.0% |
About Dr. Norman Baker, M.D
Dr. Norman Baker, M.D is a Glaucoma Specialist healthcare provider based in Columbus, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/15/2005. The National Provider Identifier (NPI) number assigned to this provider is 1790761476.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Norman Baker, M.D has received a total of $7,457 in payments from pharmaceutical and medical device companies, with $297.79 received in 2024. These payments were reported across 127 transactions from 24 companies. The most common payment nature is "Honoraria" ($5,000).
As a Medicare-enrolled provider, Baker has provided services to 9,335 Medicare beneficiaries, totaling 10,802 services with total Medicare billing of $854,832. Data is available for 4 years (2020–2023), covering 71 distinct procedure/service records.
Practice Information
- Specialty Glaucoma Specialist
- Other Specialties Ophthalmology
- Location Columbus, OH
- Active Since 12/15/2005
- Last Updated 12/20/2020
- Taxonomy Code 207WX0009X
- Entity Type Individual
- NPI Number 1790761476
Products in Payments
- Rhopressa (Drug) $298.34
- LUMIGAN (Drug) $292.50
- XIIDRA (Drug) $206.37
- VYZULTA (Drug) $200.91
- DUREZOL (Drug) $112.74
- INVELTYS (Drug) $98.79
- ACTHAR (Biological) $96.77
- VUITY (Drug) $85.13
- LOTEMAX SM (Drug) $65.70
- MIEBO (Drug) $64.16
- BESIVANCE (Drug) $60.00
- PROLENSA (Drug) $55.62
- rocklatan (Drug) $54.89
- RESTASIS (Drug) $40.48
- Rocklatan (Drug) $39.61
- TRAVATAN Z (Drug) $32.44
- TEPEZZA (Biological) $30.28
- BOTOX (Biological) $27.59
- OXERVATE (Drug) $23.11
- Ahmed Glaucoma Valve (Device) $20.98
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Glaucoma Specialist Doctors in Columbus
David Lehmann, M.d, M.D
Glaucoma Specialist — Payments: $58,086
Peter Chen, Md, MD
Glaucoma Specialist — Payments: $4,115
Megan Chambers, M.d, M.D
Glaucoma Specialist — Payments: $3,392
Dr. Gloria Fleming, Md, MD
Glaucoma Specialist — Payments: $1,948